MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2340/sju.v61.46418

Медицинская библиотека · Scandinavian journal of urology · 2026

Validation of the Stockholm3 test for prostate cancer detection in a nationwide Finnish private primary care cohort.

Santti Henrikki, Matikainen Mika, Hotakainen Kristina

СтатьяНаблюдательное исследованиеВалидационное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

The Stockholm3 test combines clinical variables and biomarkers to improve the diagnosis of clinically significant prostate cancer (csPCa). We aimed to validate and compare its performance to prostate-specific antigen (PSA)-based decision-making.

MATERIAL AND

METHODS

We conducted a prospective observational cohort study at a nationwide Finnish private primary care provider between July 2017 and February 2018. We included 1,379 men scheduled for PSA tests, excluding 74 men with missing PSA results or previously diagnosed prostate cancer. The clinical assessment was based on the PSA value and other clinical parameters, with clinicians unaware of the Stockholm3 result. We compared PSA-based decision-making with counterfactual Stockholm3 reflex testing.

RESULTS

Among the 1,305 men, the median age was 58 (interquartile range [IQR]: 51-64). PSA was ≥3 ng/mL in 209/1,305 (16%) men and above the age-specific reference limit in 119/1,305 (9%) men. Among men with PSA ≥1.5 ng/mL, a Stockholm3 Risk Score ≥15% would have selected 44% fewer men for further diagnostic evaluation than PSA ≥3 ng/mL (117/469 vs. 209/469). Over 6 years of registry-based follow-up, men with a Stockholm3 Risk Score ≥15% despite PSA below the age-specific reference limit represented a clinically relevant subgroup with subsequent csPCa diagnoses. The main limitation of this study was its observational design.

CONCLUSIONS

The hypothetical clinical implementation of Stockholm3 reflex testing would have reduced referrals, helped standardise decision-making, and identified a different group of men for further diagnostic evaluation.

Для цитирования: Santti Henrikki, Matikainen Mika, Hotakainen Kristina. Validation of the Stockholm3 test for prostate cancer detection in a nationwide Finnish private primary care cohort.. Scandinavian journal of urology. 2026. DOI: 10.2340/sju.v61.46418.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.